Debiopharm International SA Selects Veeva Vault eTMF for eTMF Collaboration

April 18, 2018

Applied Clinical Trials

Veeva Systems announced that Debiopharm International SA, part of Swiss-based biopharmaceutical company Debiopharm Group™, has selected Veeva Vault eTMF for eTMF collaboration on a single, cloud-based application. Previously, Debiopharm’s external partners were unable to access the company's on-premise eTMF, so CROs used their own systems and transferred documents periodically.

Read the full release here.

Related Content:

News